Response
- PMID: 26389154
- PMCID: PMC4836811
- DOI: 10.1093/jnci/djv205
Response
Comment on
-
RE: Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer.J Natl Cancer Inst. 2015 Sep;107(9):djv207. doi: 10.1093/jnci/djv207. J Natl Cancer Inst. 2015. PMID: 26376497 Free PMC article. No abstract available.
References
-
- Pusztai L. Anatomy and Biology: Two Complementary Sides of Breast Cancer Prognostication. J Clin Oncol. 2011:4347–4348. - PubMed
-
- Richman SD, Seymour MT, Chambers P, et al. KRAS and BRAF mutations in advanced colorectal cancer are associated with poor prognosis but do not preclude benefit from oxaliplatin or irinotecan: results from the MRC FOCUS trial. J Clin Oncol. 2009;27 (35):5931–5937. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
